The rising demand for advanced drugs is likely to create lucrative growth opportunities for the Global Veterinary Drugs Market, finds Fortune Business Insights in their new study. The study is titled “Veterinary Drugs Market: Global Market Analysis, Insights, and Forecasts, 2018 – 2025.” According to the study, the Global Veterinary Drugs Market will reach a valuation of US$ 27,570 Mn by 2025 from US$ 17,870.6 Mn in 2017, and exhibit a promising CAGR of 5.6% over the aforementioned forecast period.
Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/veterinary-drugs-market-100171
Major Table of Content for Veterinary Drugs Market:
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
- Executive Summary
- Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
- Key Insights
4.1 Pipeline Analysis of Veterinary Drugs
4.2 Overview of Company Share Analysis
4.3 Overview of Strategies by Key Market Leaders
4.4 Key Industry Developments such as Mergers & Acquisitions
4.5 New Product Launches
4.6 Regulatory Scenario
4.7 Overview of Cost Analysis
Some of the Main Key Players Covered in the Report:
- Intervet Inc.
- Boehringer Ingelheim
- Vetoquinol S.A.
- Bayer AG
- Other players
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies & Drug Stores
By Route of Administration
The Asia Pacific to Exhibit Fastest Growth Rate
The Global Veterinary Drugs Market rate of animal adoption is more in North America as compared to other regions. This, coupled with, the introduction of new animal-related products in the region will help it emerge dominant at a global scale. In 2017, North America held the highest share in the global veterinary drugs market and was valued at US$ 6290.1 Mn. It is also expected to continue dominating the market through the forecast period.
More Trending Topics From Fortune Business [email protected]